Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if PTHS is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
9 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 8 days ago
Red flags: 13
23 filers reported a long position in PTHS for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| AIGH Capital Management LLC | $9.3M | 329.1K | New |
| Murchinson Ltd. | $8.6M | 304.3K | +2.7% |
| Ikarian Capital, LLC | $7.3M | 256.6K | Unchanged |
| BOOTHBAY FUND MANAGEMENT, LLC | $2.9M | 102K | +24.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.7M | 97.1K | +4.3% |
| CANTOR FITZGERALD, L. P. | $1.1M | 38.1K | -8% |
| J. Goldman & Co LP | $1.1M | 38.1K | -24.5% |
| DIADEMA PARTNERS LP | $700.1K | 24.8K | Unchanged |
| WEXFORD CAPITAL LP | $632K | 22.4K | New |
| Knott David M Jr | $623.8K | 22.1K | +4.7% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.